Literature DB >> 9083345

Geographical variation in the standardized years of potential life lost ratio (SYPLR) in women dying from malignancies of the breast in England and Wales.

P Yuen1, J Haybittle, D Machin.   

Abstract

Geographical variation in the standardized years of potential life lost ratio (SYPLR) in women aged 20-74 dying from breast cancer has been mapped by local authority district in England and Wales and compared with the variation as described by the standardized mortality ratio (SMR). The geographical distribution of areas of low and high SMRs is similar to that observed some 15 years earlier, showing an increase from north to south. In contrast, the pattern of SYPLRs shows a less obvious trend. Years of life lost because of breast cancer mortality were particularly high in eight of the 401 county districts (SYPLR 1.22-1.48) and particularly low in nine (0.60-0.86). Mapping SYPLRs for breast cancer gives a different pattern from mapping SMRs, and one which is possibly more appropriate for targeting resources in circumstances in which death at younger age will have major social consequences. Care is required in interpreting maps indicating high and low rates in the presence of multiple comparisons. However, the range of values observed is suggestive of the need to investigate districts with contrasting values of SYPLR with respect to the inter-relationships between sociodemographic characteristics, duration of symptoms, clinical presentation and treatment efficacy.

Entities:  

Mesh:

Year:  1997        PMID: 9083345      PMCID: PMC2222757          DOI: 10.1038/bjc.1997.182

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  A standardized rate for mortality defined in units of lost years of life.

Authors:  W HAENSZEL
Journal:  Am J Public Health Nations Health       Date:  1950-01

2.  Injury Mortality Atlas of the United States, 1979-1987.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1991-12-13       Impact factor: 17.586

3.  Multiple comparisons in disease mapping.

Authors:  J Haybittle; P Yuen; D Machin
Journal:  Stat Med       Date:  1995 Nov 15-30       Impact factor: 2.373

4.  Potential years of life lost: what is the denominator?

Authors:  A K Marlow
Journal:  J Epidemiol Community Health       Date:  1995-06       Impact factor: 3.710

5.  Impact of AIDS on mortality in San Francisco, 1979-1986.

Authors:  L D Saunders; G W Rutherford; G F Lemp; J L Barnhart
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

Review 6.  Cancer patient survival by socioeconomic status in seven countries: a review for six common cancer sites [corrected].

Authors:  C T Schrijvers; J P Mackenbach
Journal:  J Epidemiol Community Health       Date:  1994-10       Impact factor: 3.710

7.  Women who decline breast screening.

Authors:  U Maclean; D Sinfield; S Klein; B Harnden
Journal:  J Epidemiol Community Health       Date:  1984-12       Impact factor: 3.710

8.  Incidence of cancer in Bradford Asians.

Authors:  R M Barker; M R Baker
Journal:  J Epidemiol Community Health       Date:  1990-06       Impact factor: 3.710

9.  Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group.

Authors:  R Sainsbury; L Rider; A Smith; A MacAdam
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

10.  Deprivation and survival from breast cancer.

Authors:  C T Schrijvers; J P Mackenbach; J M Lutz; M J Quinn; M P Coleman
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more
  2 in total

1.  Geographical variation in cancer survival in England, 1991-2006: an analysis by Cancer Network.

Authors:  Sarah Walters; Manuela Quaresma; Michel P Coleman; Emma Gordon; David Forman; Bernard Rachet
Journal:  J Epidemiol Community Health       Date:  2011-02-14       Impact factor: 3.710

2.  Geographical variation in breast cancer survival rates for women diagnosed in England between 1992 and 1994.

Authors:  M A Mullee; B De Stavola; M Romanengo; M P Coleman
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.